Industry litigation – Page 18
-
Business
Amgen seeks injunction to protect patents
Sanofi and Regeneron sued over cholesterol-regulating antibodies
-
BusinessIndian manufacturers hit back over quality claims
Study showing drugs exported to Africa are substandard prompts backlash from generic drugmakers
-
Business
US tax changes ripple into merger deals
Efforts to curb tax-avoiding ‘inversion’ deals will slow, but not stop, the wave
-
Business
Dow’s $1bn price-fixing fine upheld
Firm loses its appeal against damages for fixing polyurethane prices
-
-
Business
Gilead licenses generic hepatitis C drug in India
Company aims to head off competition and grab a slice of royalties
-
Business
US drops restrictions on more GM seeds
Dow’s herbicide-resistant corn and soybeans spark renewed criticism from environmental campaigners
-
BusinessBP faces $18bn fine over Deepwater
US judge rules that BP’s recklessness caused blowout through ‘gross negligence or willful misconduct’, but the firm will appeal
-
Business
Halliburton settles Deepwater Horizon claims
Company will pay $1.1bn for damage to property and commercial fishing
-
Business
DuPont settles pollution charges for $1.3m
Allegations relate to eight hazardous chemical leaks in West Virginia between 2006 and 2010
-
Business
GSK’s China troubles continue
Analysts say stings will only drive corruption into less visible channels
-
Business
Tetraethyl lead bribery case ends with four executives convicted
Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia
-
BusinessInvestigators find cause of West Virginia chemical spill
Holes in uninspected storage tanks led to leak that contaminated water supplies
-
BusinessEMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
Business
Inhaled insulin approved in US
European committee recommends approval for generic long-acting insulin
-
Business
Drug giants settle mismarketing lawsuits
Pfizer and GSK settle claims over promoting drugs for unapproved uses in the US
-
Business
Generics giants jostle over pain drug
Mylan and Actavis contest Teva’s generic celecoxib exclusivity
-
Business
Boehringer to settle blood thinner drug suits for $650m
Company confident in drug safety but says court cases are too risky
-
Business
Lilly protests $450m Brazilian fine
Firm says chemicals employees were allegedly exposed to were never used at site
-
Business
Chinese police hand GSK bribery case to prosecutors
Investigation alleges senior manager ordered staff to hand out bribes